Aethlon Medical, Inc.
AEMD
$1.65
-$0.04-2.33%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 39.66% | -17.62% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 39.66% | -17.62% | |||
| Operating Income | -39.66% | 17.62% | |||
| Income Before Tax | -35.71% | 15.60% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -35.71% | 15.60% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -35.71% | 15.60% | |||
| EBIT | -39.66% | 17.62% | |||
| EBITDA | -41.80% | 18.31% | |||
| EPS Basic | 34.46% | 55.91% | |||
| Normalized Basic EPS | 32.96% | 56.90% | |||
| EPS Diluted | 34.46% | 55.91% | |||
| Normalized Diluted EPS | 32.96% | 56.90% | |||
| Average Basic Shares Outstanding | 107.07% | 91.47% | |||
| Average Diluted Shares Outstanding | 107.07% | 91.47% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||